Cargando…

The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival

Vasohibin-1 (VASH1) is expressed in vascular endothelial cells stimulated by several angiogenic growth factors and displays autocrine activity to regulate angiogenesis via a negative feedback mechanism. In this study, we investigated the effect of VASH1 on ovarian cancer progression using VASH1-expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	TAKAHASHI, YOSHIFUMI, SAGA, YASUSHI, KOYANAGI, TAKAHIRO, TAKEI, YUJI, MACHIDA, SIZUO, TANEICHI, AKIYO, MIZUKAMI, HIROAKI, SATO, YASUFUMI, MATSUBARA, SHIGEKI, FUJIWARA, HIROYUKI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665704/ https://www.ncbi.nlm.nih.gov/pubmed/26460696 http://dx.doi.org/10.3892/ijo.2015.3193

Ejemplares similares

Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016)

Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer
por: Koyanagi, Takahiro, et al.
Publicado: (2021)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)

Disseminated Intravascular Coagulopathy Caused by Uterine Leiomyoma with Sarcoma-Like Findings on Magnetic Resonance Imaging
por: Taneichi, Akiyo, et al.
Publicado: (2014)

Community-Based Interventions to Improve HPV Vaccination Coverage among 13- to 15-Year-Old Females: Measures Implemented by Local Governments in Japan
por: Fujiwara, Hiroyuki, et al.
Publicado: (2013)

Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report
por: Umihira, Shuntaro, et al.
Publicado: (2022)

Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trial
por: Fujiwara, Hiroyuki, et al.
Publicado: (2015)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis
por: Kitahara, Shuji, et al.
Publicado: (2014)

Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
por: Miyashita, Hiroki, et al.
Publicado: (2012)

The roles of vasohibin and its family members: Beyond angiogenesis modulators
por: Du, Hua, et al.
Publicado: (2017)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
por: Nasu, Tatsuyo, et al.
Publicado: (2009)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
por: Yoshiba, Takahiro, et al.
Publicado: (2019)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
por: WANG, DONGDONG, et al.
Publicado: (2011)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway
por: WANG, DONGDONG, et al.
Publicado: (2016)

Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation
por: SATO, NAOTO, et al.
Publicado: (2012)

Elevated METTL9 is associated with peritoneal dissemination in human scirrhous gastric cancers
por: Hara, Toshifumi, et al.
Publicado: (2022)

Requisite role of vasohibin‐2 in spontaneous gastric cancer formation and accumulation of cancer‐associated fibroblasts
por: Suzuki, Yasuhiro, et al.
Publicado: (2017)

Vasohibin-1 suppresses colon cancer
por: Liu, Shuai, et al.
Publicado: (2015)

Structural basis of tubulin detyrosination by vasohibins
por: Li, Faxiang, et al.
Publicado: (2019)

Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer
por: Feng, Ming-Liang, et al.
Publicado: (2023)

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020)

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
por: Watatani, Hiroyuki, et al.
Publicado: (2014)

High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
por: Watanabe, Tatsuaki, et al.
Publicado: (2018)

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1
por: Zhou, Shi-you, et al.
Publicado: (2010)

Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization
por: Onami, Hideyuki, et al.
Publicado: (2013)

Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2
por: Horie, Sachiko, et al.
Publicado: (2023)

Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer
por: Kobayashi, Hiroaki, et al.
Publicado: (2017)

Structural insights into tubulin detyrosination by vasohibins-SVBP complex
por: Liu, Xi, et al.
Publicado: (2019)

Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice
por: Song, Kang-Moon, et al.
Publicado: (2021)

Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ouedhk99j20s7j8k9jcekp2vk